Harvard Pilgrim Health Care Home
  HPHConnect
 
  Learn more.
  Sign up for HPHConnect.
Medical Management
E-Transactions
HPHConnect
Pharmacy
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Newsroom
Office Support
Products
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
 
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

October 2017

P&T Committee Updates


At the Sept. 11, 2017 meeting, the Harvard Pilgrim Pharmacy & Therapeutics Committee reviewed two medications and decided the following:

P&T Committee Review and Decisions

Name

Description and Indication

Decision

Tymlos (abaloparatide)

Treatment of postmenopausal women with osteoporosis at high risk for fracture.

  • Premium formulary: moved to preferred brand tier with prior authorization
  • Value formulary: added to preferred brand tier with prior authorization
  • Medicare Advantage Formulary: added to preferred brand tier with prior authorization

Xiidra (lifitegrast) ophthalmic solution 

Treatment of the signs and symptoms of
dry eye disease (DED).

  • Premium formulary: moved to preferred brand tier with quantity limit
  • Value formulary: added to preferred brand tier with quantity limit
  • Medicare Advantage formulary: moved to preferred brand tier with quantity limit

Email this article to a colleague   


Network Matters Archives

Download printer-friendly version

HPHCURRENT EVENTS

Harvard Pilgrim’s New “Estimate My Cost” Transparency Tool

Medicare Advantage: Important Information about Jimmo Settlement

Medicare Advantage Policy Updates for 2018

New Products and Benefits for 2018

CLINICIAN CORNER

Prior Authorization for Hip, Knee, and Shoulder Surgeries

Updates to Cholecystectomy Medical Review Criteria

Synagis for Upcoming RSV Season

Therapeutic Yoga for Chronic Pain and Other Conditions

P&T Committee Updates

Specialty Pharmacy Program Updates

ADHD Diagnosis and Follow-up Care

OFFICE ASSISTANT

Reporting Modifier 50 for Bilateral Procedures

2018 CPT and HCPCS codes

PUBLICATION INFORMATION

Eric H. Schultz,
President and Chief Executive Officer

Robert Farias,
Senior Vice President, Network Strategy

Annmarie Dadoly,
Editor

Joseph O'Riordan,
Writer

Kristin Edmonston,
Production Coordinator